Brief: Chimerix Announces Exclusive Global License Agreement With Symbio Pharma For Brincidofovir

SymBio Pharmaceuticals

01/10/2019 01:57

Sept 30 (Reuters) - Chimerix Inc  CMRX.O :
    * CHIMERIX ANNOUNCES EXCLUSIVE GLOBAL LICENSE AGREEMENT WITH
SYMBIO PHARMACEUTICALS FOR BRINCIDOFOVIR
    * CHIMERIX INC- CHIMERIX TO RECEIVE UP TO $180 MILLION IN
POTENTIAL CLINICAL, REGULATORY, AND COMMERCIAL MILESTONES AND IS
ELIGIBLE FOR DOUBLE DIGIT ROYALTIES

Source text for Eikon:  ID:nGNXbj79ct 
Further company coverage:  CMRX.O 

 (Reuters.Briefs@thomsonreuters.com)